Access cutting-edge asthma treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access asthma specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related asthma treatment provided free
This is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerbations in urban children and adolescents with T2-high exacerbation-prone asthma.
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this asthma clinical trial in Washington Dc, DC
If you're searching for asthma treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.